JPMorgan BetaBuilders Europe ETF : BBEU

Price Target

›

BBEU

Stock Data

$76.43

$0.13 (0.17%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All BBEU Articles

2 Articles

Austin Smith | Mar 26, 2026 at 9:10 AM EDT

How the Euro at $1.16 Changes Everything About These 3 Europe ETFs

IEUR, BBEU, and DBEU all track European equities, but the one you pick will determine whether the euro’s recent surge…

Austin Smith | Dec 29, 2025 at 10:07 AM EST

Investors Say Europe Is Cooked, But JP Morgan’s Euro ETF Is Destroying The S&P and Hot AI Stocks

When currency swings punish domestic investors and geopolitical headlines scream crisis, the stocks underneath often tell a different story. European…

JPMorgan BetaBuilders Europe ETF : BBEU

BBEU

$76.43

All BBEU Articles

How the Euro at $1.16 Changes Everything About These 3 Europe ETFs

Investors Say Europe Is Cooked, But JP Morgan’s Euro ETF Is Destroying The S&P and Hot AI Stocks

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

JPMorgan BetaBuilders Europe ETF : BBEU

BBEU

$76.43

All BBEU Articles

How the Euro at $1.16 Changes Everything About These 3 Europe ETFs

Investors Say Europe Is Cooked, But JP Morgan’s Euro ETF Is Destroying The S&P and Hot AI Stocks

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026